Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pinoxin for the Prevention of Radiation-Induced Skin Injury
NCT07545720Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Sep 2024
- Primary completion
- May 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pinoxin in radiation-induced skin injury (RSI), sponsored by Fudan University. Started Sep 2024; status: recruiting.
02
Drugs
pinoxin
03
Conditions
radiation-induced skin injury (RSI)
Beyond the preview
Go deeper on NCT07545720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07545720.